Letters

Hepatitis B, lamivudine, and HIV

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7303.51 (Published 07 July 2001) Cite this as: BMJ 2001;323:51
  1. Usha Kuchimanchi (kuchimanchi@doctors.org.uk), specialist registrar,
  2. Guy Rooney, consultant physician
  1. Department of Genitourinary Medicine, Radcliffe Infirmary, Oxford OX2 6HE
  2. Department of Genitourinary Medicine, Princess Margaret Hospital, Swindon SN1 4JU

    EDITOR—Ryder and Beckingham reviewed the management and treatment of chronic viral hepatitis.1 Lamivudine has a good safety profile and has been shown to be beneficial for patients requiring treatment for hepatitis B infection. It …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe